institution
Satilla Cancer Treatment Centers, Llc
Specialist in Waycross, Georgia
NPI 1447467717

Satilla Cancer Treatment Centers, Llc is a Specialist based in Waycross, GA. Satilla Cancer Treatment Centers, Llc practices in Waycross, GA. The NPI Number for Satilla Cancer Treatment Centers, Llc is 1447467717 and holds a License No. (Georgia).

The current practice location address for Satilla Cancer Treatment Centers, Llc is 1451 Church St, Waycross, GA and can be reached out via phone at 912-283-3087 and via fax at 912-283-7337.

Location: 1451 Church St, Waycross, GA, 31501-3531
institution
Provider Profile Details
NPI Number
1447467717
Provider Name
Satilla Cancer Treatment Centers, Llc
Credential
Provider Entity Type
Organization
Address
1451 Church St, Waycross, GA, 31501-3531
Phone Number
912-283-3087
Fax Number
912-283-7337
Provider Enumeration Date
05/17/2007
Last Update Date
03/09/2024
tick
Provider's Legacy Identifiers
Identifier Type State Issuer
11D1096390 01 GA CLIA
202G708768 01 GA MEDICARE PTAN
300027669B 05 GA
DQ2362 01 GA RR MCR
institution
Provider Business Practice Location Address Details
Address
1451 Church St
City
State
Zip
31501-3531
Phone Number
912-283-3087
Fax Number
912-283-7337
person
Provider Business Mailing Address Details
Address
1451 Church St
City
State
Zip
31501-3531
Phone Number
912-283-3087
Fax Number
912-283-7337
person
Provider's Taxonomy Details 1
Type
Other Service Providers
Classification
Specialist
Speciality
-
Taxonomy
License No.
()
Definition
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
semi-verified symbol
Badge

Use the following badge on your website to showcase your NPI number and verified status. In a field with over 8 million healthcare providers in the United States, it is important to establish your identity clearly. Displaying this badge signifies that your information is both accurate and up-to-date.